8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________________

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  February 17, 2011

Emergent BioSolutions Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware	001-33137	14-1902018
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

2273 Research Boulevard, Suite 400, Rockville, Maryland	20850
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code:  (301) 795-1800

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.02 Termination of a Material Definitive Agreement.

On February 17, 2011, Emergent BioSolutions Inc. ("Registrant") entered into a letter agreement ("Termination Agreement") with East West Resources Corporation ("EWR") terminating the Services Agreement, dated as of August 1, 2006 (“Services Agreement”), by and between the Registrant and EWR, effective as of December 30, 2010. Under the Services Agreement, EWR had provided certain transportation and logistical services to the Registrant that were substantially completed by the effective date of termination.

Item 9.01.                      Financial Statements and Exhibits.

(d)           Exhibits.

10.1 Letter agreement between Emergent BioSolutions Inc. and East West Resources Corporation, dated February 17, 2011

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:  February 23, 2011	EMERGENT BIOSOLUTIONS INC.
	By:	/s/R. Don Elsey R. Don Elsey Chief Financial Officer

EX-10.1

EXHIBIT 10.1

February 17, 2011

Greg Siegrist

President

East West Resources Corporation

12001 Glen Road

Potomac, MD 20854

Re:  Services Agreement with Emergent BioSolutions Inc.

Dear Mr. Siegrist:

Reference is made to that certain Services Agreement (the “Agreement”), dated as of August 1, 2006, by and between East West Resources Corporation (“EWR”) and Emergent BioSolutions Inc. (“Emergent”). In consideration of the mutual agreement of EWR and Emergent, the Agreement is hereby terminated effective as of December 30, 2010 (the “Termination Date”), and shall be of no further force or effect and no further payments shall be due thereunder from and after the Termination Date.

Sincerely,

Emergent BioSolutions Inc.

By:/s/R. Don Elsey

Name: R. Don Elsey

Title:   Senior Vice President

and Chief Financial Officer

Accepted and Agreed:

East West Resources Corporation

By: /s/Greg Siegrist

Name:                      Greg Siegrist

Title:           President